JPRN-jRCTs031230111招募中3 期
Sitafloxacin versus moxifloxacin-based sequential treatment for Mycoplasma genitalium infections, multi-center, open-label, randomized controlled trial.
Ando Naokatsu0 个研究点目标入组 112 人开始时间: 2023年6月6日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 112
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1. Patients provided an informed consent in writing.
- •2. Patients aged 18 years or older.
- •3. Patients diagnosed with Mycoplasma genitalium by urine or rectal sample
排除标准
- •1. Individuals with pregnancy
- •2. Individuals with a history of known hypersensitivity to sitafloxacin, doxycycline or moxifloxacin.
- •3. Individuals who are judged by their physicians in charge to be ineligible for any reason
研究者
相似试验
尚未招募
3 期
Investigating the effect of moxifloxacin in Helicobacter infectioIRCT20240128060832N1Ahvaz University of Medical Sciences246
已完成
不适用
Evaluation of efficacy of Sitafloxacin in treatment of moderate to severe acute rhinosinusitisacute rhinosinusitisJPRN-UMIN000009567Wakayama-Okayama Otolaryngology Pharma100
进行中（未招募）
不适用
Evaluation of a Moxifloxacin-Based, Isoniazid-Sparing Regimen for Tuberculosis Treatment TBTC/UITB Study 28 - Moxifloxacin for IsoniazidEUCTR2005-003312-29-ESTB Investigation Unit of Barcelona410
已完成
3 期
BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration PneumoniaPneumonia, AspirationLung AbscessNCT01045902Bayer139
招募中
不适用
Efficacy of sitafloxacin for urinary tract infectioJPRN-jRCTs061200052Takehiro Iwata92